Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients
Clinical trial NCT04409522 · UNKNOWN
Trial details
- NCT number
- NCT04409522
- Sponsor
- Mohammad Sadegh Bagheri Baghdasht
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-12
- Primary completion
- 2020-06-05
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.